These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 33815838)

  • 1. Cardiac Injury Biomarkers and the Risk of Death in Patients with COVID-19: A Systematic Review and Meta-Analysis.
    Alzahrani SH; Al-Rabia MW
    Cardiol Res Pract; 2021; 2021():9363569. PubMed ID: 33815838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Value of combined detection of biomarkers in early diagnosis and prognosis of patients with septic myocardial injury].
    Li Z; Cui S; Geng L
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2021 Apr; 33(4):443-448. PubMed ID: 34053488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiac injury associated with severe disease or ICU admission and death in hospitalized patients with COVID-19: a meta-analysis and systematic review.
    Li X; Pan X; Li Y; An N; Xing Y; Yang F; Tian L; Sun J; Gao Y; Shang H; Xing Y
    Crit Care; 2020 Jul; 24(1):468. PubMed ID: 32723362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Markers of myocardial injury in the prediction of short-term COVID-19 prognosis.
    Calvo-Fernández A; Izquierdo A; Subirana I; Farré N; Vila J; Durán X; García-Guimaraes M; Valdivielso S; Cabero P; Soler C; García-Ribas C; Rodríguez C; Llagostera M; Mojón D; Vicente M; Solé-González E; Sánchez-Carpintero A; Tevar C; Marrugat J; Vaquerizo B
    Rev Esp Cardiol (Engl Ed); 2021 Jul; 74(7):576-583. PubMed ID: 33153955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiac biomarkers, cardiac injury, and comorbidities associated with severe illness and mortality in coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis.
    Zhu Z; Wang M; Lin W; Cai Q; Zhang L; Chen D; Liu F; Xiong X; Chu J; Peng J; Chen K
    Immun Inflamm Dis; 2021 Dec; 9(4):1071-1100. PubMed ID: 34405950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Longitudinal correlation of biomarkers of cardiac injury, inflammation, and coagulation to outcome in hospitalized COVID-19 patients.
    Li C; Jiang J; Wang F; Zhou N; Veronese G; Moslehi JJ; Ammirati E; Wang DW
    J Mol Cell Cardiol; 2020 Oct; 147():74-87. PubMed ID: 32827510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multi-biomarker risk stratification of N-terminal pro-B-type natriuretic peptide, high-sensitivity C-reactive protein, and cardiac troponin T and I in end-stage renal disease for all-cause death.
    Apple FS; Murakami MM; Pearce LA; Herzog CA
    Clin Chem; 2004 Dec; 50(12):2279-85. PubMed ID: 15364888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevation of cardiac troponin T, but not cardiac troponin I, in patients with neuromuscular diseases: implications for the diagnosis of myocardial infarction.
    Rittoo D; Jones A; Lecky B; Neithercut D
    J Am Coll Cardiol; 2014 Jun; 63(22):2411-20. PubMed ID: 24747102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomised Assessment of Treatment using Panel Assay of Cardiac markers--Contemporary Biomarker Evaluation (RATPAC CBE).
    Collinson PO; Gaze DC; Thokala P; Goodacre S
    Health Technol Assess; 2013; 17(15):v-vi, 1-122. PubMed ID: 23597479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiac Troponin-I, A Biomarker for Predicting COVID-Induced Myocardial Damage Prognosis.
    Rehman A; Yousuf S; Maken GR; Naqvi SRA; Murtaza G; Ahmad A
    J Coll Physicians Surg Pak; 2023 May; 33(5):498-503. PubMed ID: 37190681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sensitive troponin assays and N-terminal pro-B-type natriuretic peptide in acute coronary syndrome: prediction of significant coronary lesions and long-term prognosis.
    Gravning J; Smedsrud MK; Omland T; Eek C; Skulstad H; Aaberge L; Bendz B; Kjekshus J; Mørkrid L; Edvardsen T
    Am Heart J; 2013 May; 165(5):716-24. PubMed ID: 23622908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A multi-marker approach for the prediction of adverse events in patients with acute coronary syndromes.
    Cameron SJ; Sokoll LJ; Laterza OF; Shah S; Green GB
    Clin Chim Acta; 2007 Feb; 376(1-2):168-73. PubMed ID: 17011538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Markers of myocardial injury in the prediction of short-term COVID-19 prognosis].
    Calvo-Fernández A; Izquierdo A; Subirana I; Farré N; Vila J; Durán X; García-Guimaraes M; Valdivielso S; Cabero P; Soler C; García-Ribas C; Rodríguez C; Llagostera M; Mojón D; Vicente M; Solé-González E; Sánchez-Carpintero A; Tevar C; Marrugat J; Vaquerizo B
    Rev Esp Cardiol; 2021 Jul; 74(7):576-583. PubMed ID: 33262553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Prognostic Value of Cardiac Biomarkers and Echocardiography in Critical COVID-19.
    Zwaenepoel B; Dhont S; Hoste E; Gevaert S; Schaubroeck H
    Front Cardiovasc Med; 2021; 8():752237. PubMed ID: 34805307
    [No Abstract]   [Full Text] [Related]  

  • 15. Routinely measured cardiac troponin I and N-terminal pro-B-type natriuretic peptide as predictors of mortality in haemodialysis patients.
    Eriguchi M; Tsuruya K; Lopes M; Bieber B; McCullough K; Pecoits-Filho R; Robinson B; Pisoni R; Kanda E; Iseki K; Hirakata H
    ESC Heart Fail; 2022 Apr; 9(2):1138-1151. PubMed ID: 35026869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Predictive value of early phrase echocardiography and cardiac biological markers in patients with severe sepsis: a five-year single-center retrospective study].
    Zang X; Chen W; Sheng B; Zhao L; Gu X; Zhen J; Liu P
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2018 Apr; 30(4):332-336. PubMed ID: 29663994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Redefining Cardiac Biomarkers in Predicting Mortality of Inpatients With COVID-19.
    Qin JJ; Cheng X; Zhou F; Lei F; Akolkar G; Cai J; Zhang XJ; Blet A; Xie J; Zhang P; Liu YM; Huang Z; Zhao LP; Lin L; Xia M; Chen MM; Song X; Bai L; Chen Z; Zhang X; Xiang D; Chen J; Xu Q; Ma X; Touyz RM; Gao C; Wang H; Liu L; Mao W; Luo P; Yan Y; Ye P; Chen M; Chen G; Zhu L; She ZG; Huang X; Yuan Y; Zhang BH; Wang Y; Liu PP; Li H
    Hypertension; 2020 Oct; 76(4):1104-1112. PubMed ID: 32673499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distribution and prognostic value of high-sensitivity cardiac troponin T and I across glycemic status: a population-based study.
    Zhang J; Li X; Zhang S; Wang Z; Tian R; Xu F; Chen Y; Li C
    Cardiovasc Diabetol; 2024 Feb; 23(1):83. PubMed ID: 38402162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of elevated cardiac and inflammatory biomarkers in patients with severe COVID-19: a single-center, retrospective study.
    Kumar N; Ahmad S; Mahto M; Kumar A; Singh PK
    Emerg Crit Care Med; 2022 Sep; 2(3):122-127. PubMed ID: 37521815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of 2019 novel coronavirus on heart injury: A Systematic review and Meta-analysis.
    Li JW; Han TW; Woodward M; Anderson CS; Zhou H; Chen YD; Neal B
    Prog Cardiovasc Dis; 2020; 63(4):518-524. PubMed ID: 32305557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.